Presenter
Merck Healthcare Pty Ltd
Louise Young is an Associate Medical Director - Oncology at the pharmaceutical company Merck Healthcare Pty Ltd and responsible for Medical Affairs within the Oncology Business Unit, working within multiple solid tumour streams. Louise has worked within the Life Sciences arena in Australia both in academia and industry for over ten years after completing a PhD in Immunology at The Walter and Eliza Hall Institute of Medical Research.
Presentations by Louise Young
Show All
presentation
Tepotinib in patients with MET exon 14 (METex14) skipping NSCLC: Analysis of all patients from VISION Cohorts A and C
Dr Louise Young
Clinical response to tepotinib according to circulating tumor (ct)DNA biomarkers in patients with advanced NSCLC with high-level MET amplification (METamp) detected by liquid biopsy (LBx)
Dr Louise Young
Judges Comments